Luc Lasser

1.5k total citations
21 papers, 737 citations indexed

About

Luc Lasser is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Luc Lasser has authored 21 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 11 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Luc Lasser's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Liver Disease and Transplantation (5 papers). Luc Lasser is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Liver Disease and Transplantation (5 papers). Luc Lasser collaborates with scholars based in Belgium, Spain and Italy. Luc Lasser's co-authors include Massimo Primignani, Dominique Valla, Isabelle Morard, Antoine Hadengue, Juan Carlos García‐Pagán, Philippe Langlet, Sarwa Darwish Murad, Jörg Heller, Jonel Trebicka and Aurélie Plessier and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Luc Lasser

20 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luc Lasser Belgium 9 531 385 316 102 79 21 737
Philippe Langlet France 9 525 1.0× 364 0.9× 319 1.0× 103 1.0× 82 1.0× 11 748
Amar Mukund India 18 647 1.2× 457 1.2× 664 2.1× 26 0.3× 55 0.7× 136 1.2k
J Wilde United Kingdom 18 296 0.6× 177 0.5× 205 0.6× 92 0.9× 35 0.4× 34 1.1k
Andrés Brainsky United States 13 182 0.3× 177 0.5× 148 0.5× 54 0.5× 118 1.5× 40 947
Elba Llop Spain 14 997 1.9× 907 2.4× 458 1.4× 26 0.3× 18 0.2× 44 1.1k
Motohide Takashi Japan 12 655 1.2× 487 1.3× 335 1.1× 47 0.5× 13 0.2× 22 733
Jessica Glen United Kingdom 8 68 0.1× 170 0.4× 81 0.3× 41 0.4× 31 0.4× 8 374
S. Raffa Spain 9 598 1.1× 427 1.1× 386 1.2× 62 0.6× 5 0.1× 15 847
Hassan H. A‐Kader United States 12 164 0.3× 228 0.6× 289 0.9× 17 0.2× 13 0.2× 25 558
Ingrid L. Holster Netherlands 18 195 0.4× 207 0.5× 839 2.7× 137 1.3× 20 0.3× 38 1.3k

Countries citing papers authored by Luc Lasser

Since Specialization
Citations

This map shows the geographic impact of Luc Lasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Lasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Lasser more than expected).

Fields of papers citing papers by Luc Lasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Lasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Lasser. The network helps show where Luc Lasser may publish in the future.

Co-authorship network of co-authors of Luc Lasser

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Lasser. A scholar is included among the top collaborators of Luc Lasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Lasser. Luc Lasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nevens, Frederik, Thierry Gustot, Pierre‐François Laterre, et al.. (2021). A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation. JHEP Reports. 3(4). 100291–100291. 25 indexed citations
2.
Bourgeois, Stefan, Mike Cool, Xavier Verhelst, et al.. (2021). Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium : an observational study. Acta Gastro Enterologica Belgica. 84(1). 33–41. 1 indexed citations
3.
Muyldermans, Gaëtan, Rob Bielen, Stefan Bourgeois, et al.. (2020). Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis.. PubMed. 82(4). 479–485. 9 indexed citations
4.
Bourgeois, Stefan, Luc Lasser, Geert Robaeys, et al.. (2019). A multicentre, observational study on demographic and disease characteristics of patients seeking care for chronic hepatitis C in Belgium in 2016.. PubMed. 82(1). 43–52. 2 indexed citations
5.
Lasser, Luc, et al.. (2019). Giant fibrovascular polyp of the esophagus. Gastrointestinal Endoscopy. 91(2). 442–443. 2 indexed citations
6.
Degré, Delphine, Thomas Sersté, Luc Lasser, et al.. (2017). Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium. PLoS ONE. 12(1). e0170933–e0170933. 8 indexed citations
7.
Moreno, Christophe, Luc Lasser, Jean Delwaide, et al.. (2015). Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium. Hepatology. 62(1). 746. 3 indexed citations
8.
Kong, Marie‐France, et al.. (2015). A lady with NASH and choreoathetosis. Acta Clinica Belgica. 70(5). 375–376. 1 indexed citations
9.
Moreno, Carolina, et al.. (2015). Ethnic epidemiological profiles and antiviral therapy among patients infected with hepatitis C virus genotype 4: a multicenter study from Belgium.. PubMed. 78(4). 365–72. 1 indexed citations
10.
Lasser, Luc, et al.. (2014). DRESS syndrome à la phénytoïne. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 34(2). 79–81. 1 indexed citations
11.
Adler, Michael, et al.. (2013). Response of Black African patients with hepatitis C virus genotype 4 to treatment with peg-interferon and ribavirin.. PubMed. 76(3). 291–9. 1 indexed citations
12.
Seijó, Susana, Aurélie Plessier, Jildou Hoekstra, et al.. (2013). Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 57(5). 1962–1968. 173 indexed citations
13.
Francque, Sven, Stéphane De Maeght, Maciej Adler, et al.. (2011). High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.. PubMed. 74(1). 9–16. 16 indexed citations
14.
Moreno, Christophe, Philippe Langlet, Axel Hittelet, et al.. (2010). Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial. Journal of Hepatology. 53(6). 1117–1122. 83 indexed citations
15.
Gottignies, Philippe, et al.. (2009). Upper gastrointestinal bleeding related to emphysematous cholecystitis due to Clostridium perfringens. International Journal of Infectious Diseases. 14(3). e257–e258. 5 indexed citations
16.
Plessier, Aurélie, Sarwa Darwish Murad, Manuel Hernández‐Guerra, et al.. (2009). Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study. Hepatology. 51(1). 210–218. 365 indexed citations
17.
Langlet, Philippe, F D’Heygere, Jean Henrion, et al.. (2009). Clinical trial: a randomized trial of pegylated‐interferon‐α‐2a plus ribavirin with or without amantadine in treatment‐naïve or relapsing chronic hepatitis C patients. Alimentary Pharmacology & Therapeutics. 30(4). 352–363. 11 indexed citations
18.
Lasser, Luc, et al.. (2008). Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis. Clinical Nephrology. 70(7). 69–71. 20 indexed citations
19.
Lasser, Luc, et al.. (2006). [Hepatitis C in women planning a pregnancy: current opinions].. PubMed. 26(6). 487–91.
20.
Devriendt, Jacques, et al.. (2000). Fatal liver failure associated with Nevirapine in a pregnant HIV patient: The first reported case. Gastroenterology. 118(4). A1461–A1461. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Langlet Breakdown of academic impact, for papers by Amar Mukund Breakdown of academic impact, for papers by J Wilde Breakdown of academic impact, for papers by Andrés Brainsky Breakdown of academic impact, for papers by Elba Llop Breakdown of academic impact, for papers by Motohide Takashi Breakdown of academic impact, for papers by Jessica Glen Breakdown of academic impact, for papers by S. Raffa Breakdown of academic impact, for papers by Hassan H. A‐Kader Breakdown of academic impact, for papers by Ingrid L. Holster
Rankless by CCL
2026